| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.9M | +16.9% |
| Cost of Revenue | $2.8M | -15.6% |
| Gross Profit | $2.1M | +137.1% |
| R&D Expense | $418K | +0.0% |
| SG&A Expense | $3.6M | -2.6% |
| Operating Income | -$3.5M | +24.2% |
| Pre-tax Income | -$4.0M | +17.9% |
| Income Tax | $5K | — |
| Net Income | -$4.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $730K | -24.4% |
| Inventory | $890K | -33.5% |
| Current Assets | $1.8M | -40.7% |
| Total Assets | $2.7M | -41.8% |
| Current Liabilities | $8.3M | -1.7% |
| Total Liabilities | $8.5M | -7.3% |
| Stockholders' Equity | -$30.7M | -4.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.7M | +20.2% |
| Capital Expenditures | $42K | +0.0% |
| Investing Cash Flow | -$42K | +0.0% |
| Financing Cash Flow | $2.7M | -18.0% |
| Free Cash Flow | -$2.7M | +20.0% |
| +17.8% |
| EPS (Basic) | -$0.02 | +50.0% |
| EPS (Diluted) | -$0.02 | +50.0% |